At the end of this educational activity, participants should be able to:
-Review the epidemiology and tobacco consumption burden of psychiatric co-morbid nicotine dependence.
-Identify evidenced based smoking cessation strategies for those with psychiatric disorders.
-Recognize the association between varenicline and psychiatric adverse events in smokers with schizophrenia.
Visit: http://mghcme.org/ to register for a course.